Pharmaceutical companies want injunctions against patent infringers and oppose compulsory licenses, because with a few high-value patents unshielded infringers would poach and the system would collapse, whereas software companies are more ambivalent and prefer royalties.

factualpending

Speaker

Richard Epstein

Evidence Quote

“they hate compulsory licenses and they love injunctions”

Source

Richard Epstein on Property Rights and Drug Patents 2/19/2007— EconTalk
Created: 10/30/2026, 3:22:16 PM

Your notes

Loading notes...